COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
2.770
+0.110 (4.14%)
At close: Jun 27, 2025, 4:00 PM
2.750
-0.020 (-0.72%)
After-hours: Jun 27, 2025, 7:57 PM EDT
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $259.17 million as of June 27, 2025. Its market cap has decreased by -40.69% in one year.
Market Cap
259.17M
Enterprise Value
31.09M
1-Year Change
-40.69%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $259.17M, a decrease of -54.42%. That is a compound annual growth rate of -15.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 259.17M | 0.21% |
| Dec 31, 2024 | 258.63M | -52.25% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.15B |
| Johnson & Johnson | 366.18B |
| AbbVie | 329.31B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.32B |
| Abbott Laboratories | 232.29B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |